Kymera Therapeutics Inc (KYMR)
34.94
-0.66
(-1.85%)
USD |
NASDAQ |
May 17, 16:00
34.94
0.00 (0.00%)
After-Hours: 20:00
Kymera Therapeutics Market Cap: 2.144B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 2.184B |
| May 15, 2024 | 2.205B |
| May 14, 2024 | 2.153B |
| May 13, 2024 | 2.354B |
| May 10, 2024 | 2.325B |
| May 09, 2024 | 2.369B |
| May 08, 2024 | 2.362B |
| May 07, 2024 | 2.359B |
| May 06, 2024 | 2.350B |
| May 03, 2024 | 2.295B |
| May 02, 2024 | 2.227B |
| May 01, 2024 | 2.224B |
| April 30, 2024 | 2.063B |
| April 29, 2024 | 2.127B |
| April 26, 2024 | 2.048B |
| April 25, 2024 | 2.046B |
| April 24, 2024 | 2.160B |
| April 23, 2024 | 2.191B |
| April 22, 2024 | 2.108B |
| April 19, 2024 | 2.084B |
| April 18, 2024 | 2.155B |
| April 17, 2024 | 2.071B |
| April 16, 2024 | 2.082B |
| April 15, 2024 | 2.110B |
| April 12, 2024 | 2.183B |
| Date | Value |
|---|---|
| April 11, 2024 | 2.283B |
| April 10, 2024 | 2.168B |
| April 09, 2024 | 2.307B |
| April 08, 2024 | 2.231B |
| April 05, 2024 | 2.233B |
| April 04, 2024 | 2.223B |
| April 03, 2024 | 2.278B |
| April 02, 2024 | 2.309B |
| April 01, 2024 | 2.419B |
| March 28, 2024 | 2.457B |
| March 27, 2024 | 2.455B |
| March 26, 2024 | 2.413B |
| March 25, 2024 | 2.414B |
| March 22, 2024 | 2.488B |
| March 21, 2024 | 2.495B |
| March 20, 2024 | 2.465B |
| March 19, 2024 | 2.418B |
| March 18, 2024 | 2.403B |
| March 15, 2024 | 2.480B |
| March 14, 2024 | 2.415B |
| March 13, 2024 | 2.585B |
| March 12, 2024 | 2.558B |
| March 11, 2024 | 2.584B |
| March 08, 2024 | 2.658B |
| March 07, 2024 | 2.609B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
608.70M
Minimum
Oct 27 2023
3.905B
Maximum
Dec 28 2020
1.897B
Average
1.791B
Median
Mar 02 2023
Market Cap Benchmarks
| Immunic Inc | 112.60M |
| Insmed Inc | 3.679B |
| SELLAS Life Sciences Group Inc | 84.61M |
| Iovance Biotherapeutics Inc | 2.865B |
| Intellia Therapeutics Inc | 2.532B |
Market Cap Related Metrics
| PS Ratio | 27.06 |
| Price to Book Value | 3.014 |
| Price | 34.94 |
| Earnings Yield | -7.18% |